Waldenstrom's Macroglobulinemia Refractory

Also known as: Refractory Waldenstrom's Macroglobulinaemia / Waldenstrom's macroglobulinaemia refractory / Refractory Waldenström macroglobulinemia / Refractory Lymphoplasmacytic Lymphoma / Refractory Waldenstrom's Macroglobulinemia / Refractory Waldenstrom Macroglobulinemia

Drug	Drug Name	Drug Description
DB01590	Everolimus	A mammalian target of rapamycin (mTOR) kinase inhibitor used to treat various types of malignancies.

Drug	Drug Name	Target	Type
DB01590	Everolimus	Serine/threonine-protein kinase mTOR	target
DB01590	Everolimus	Cytochrome P450 3A4	enzyme
DB01590	Everolimus	Solute carrier organic anion transporter family member 1B1	transporter
DB01590	Everolimus	Solute carrier organic anion transporter family member 1B3	transporter
DB01590	Everolimus	Solute carrier organic anion transporter family member 1A2	transporter
DB01590	Everolimus	Cytochrome P450 2D6	enzyme
DB01590	Everolimus	ATP-dependent translocase ABCB1	transporter

Drug	Drug Name	Phase	Status	Count
DB17366	MB-102 CD123 CAR	Not Available	Terminated	1
DB11581	Venetoclax	Not Available	Recruiting	1
DB00928	Azacitidine	1	Active Not Recruiting	1
DB09053	Ibrutinib	1	Active Not Recruiting	2
DB09053	Ibrutinib	1	Completed	1
DB00480	Lenalidomide	1	Active Not Recruiting	2
DB00480	Lenalidomide	1	Withdrawn	1
DB08935	Obinutuzumab	1	Active Not Recruiting	1
DB09037	Pembrolizumab	1	Completed	1
DB11759	Pevonedistat	1	Active Not Recruiting	1
DB08910	Pomalidomide	1	Active Not Recruiting	1
DB11850	Ublituximab	1	Withdrawn	1
DB14989	Umbralisib	1	Withdrawn	1
DB00531	Cyclophosphamide	1 / 2	Active Not Recruiting	1
DB01073	Fludarabine	1 / 2	Active Not Recruiting	1
DB00480	Lenalidomide	1 / 2	Active Not Recruiting	1
DB09035	Nivolumab	1 / 2	Active Not Recruiting	1
DB08889	Carfilzomib	2	Terminated	1
DB00531	Cyclophosphamide	2	Completed	1
DB00091	Cyclosporine	2	Completed	1
DB09331	Daratumumab	2	Terminated	1
DB01073	Fludarabine	2	Completed	1
DB09053	Ibrutinib	2	Active Not Recruiting	1
DB09053	Ibrutinib	2	Completed	1
DB09053	Ibrutinib	2	Terminated	1
DB09054	Idelalisib	2	Completed	1
DB09570	Ixazomib	2	Active Not Recruiting	1
DB00688	Mycophenolate mofetil	2	Completed	1
DB09037	Pembrolizumab	2	Completed	1
DB00073	Rituximab	2	Terminated	1
DB18753	Sonrotoclax	2	Recruiting	1
DB15035	Zanubrutinib	2	Recruiting	1